The Relationship Between Covid-19 Infection in Pediatric Patients and Secondary Lymphoid Organs
- Conditions
- Covid19TonsillitisAdenoiditisTonsil HypertrophyAdenoid HypertrophyImmune Deficiency
- Registration Number
- NCT04646525
- Lead Sponsor
- Selcuk University
- Brief Summary
We aimed to find out whether the tonsils and nasal tissues of pediatric patients are the main factors that protects the children's immune system against COVID-19 infection.
- Detailed Description
Since it is known that the tonsil and adenoid tissues that are known as a secondary lymphoid organ, which form the first line of defense, are more active in childhood than adults, especially in the childhood age group, and since it has been scientifically shown that patients diagnosed with COVID-19 infection in the pediatric age group overcome this disease lightly than adults, we aimed to reveal whether the defined tonsil and adenoid tissues are the main factors that protect the children's immune system against COVID-19 infection.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
- Patients with COVID-19 infection.
- Patients aged between 1-16 years
- Patients whose PCR test becomes negative
- Patients with lymphoid tissue malignant disease
- Patients with known lung disease
- Patients with known systemic disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome of our study was the evaluation of pediatric patients diagnosed with COVID-19 and who had COVID-19 infection in terms of adenoid and tonsillar tissue hypertrophy and the presence of chronic or recurrent infection. 2020-2021 The structure of the tonsil and adenoid tissues will be examined by physical examination, and the presence of tonsil and adenoid hypertrophy, tonsillitis, and adenoiditis conditions will be identified. The severity of covid-19 will be determined according to the cases of patients with tonsil and adenoid tissue disorders, who are hospitalized in intensive care, have infiltration in the lungs, and receive oxygen support.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Selcuk University
🇹🇷Konya, Selcuklu, Turkey